Società | Nome | Borsa | Settore | Industria | 3 mesi | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fengyinhe Holdings | Hong Kong | Finanziario | Servizi bancari e di Investimenti | 227,7% | 264,59 Mln HKD | 0,9x | -0,17 | 0,80 HKD | 2,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Huarong International Financial | Hong Kong | Finanziario | Servizi bancari e di Investimenti | 224,1% | 1,79 Mrd HKD | -4,8x | -0,06 | 0,20 HKD | 6,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Capital VC | Hong Kong | Finanziario | Servizi bancari e di Investimenti | 114,6% | 85,52 Mln HKD | -1,1x | -0,04 | 0,19 HKD | 1,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
ARTA TechFin | Hong Kong | Finanziario | Servizi bancari e di Investimenti | 109,5% | 842,30 Mln HKD | -21,5x | -0,34 | 0,04 HKD | -2,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Holly Futures Co | Hong Kong | Finanziario | Servizi bancari e di Investimenti | 100% | 3,15 Mrd HKD | 129,7x | 1,59 | 3,13 HKD | -0,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Everest Med | Hong Kong | Salute | Prodotti farmaceutici | 96,6% | 2,44 Mrd HKD | -6,2x | 46,90 HKD | -2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
Abbisko Cayman | Hong Kong | Salute | Ricerca medica e biotecnologica | 53,3% | 3,04 Mrd HKD | -180x | -1,81 | 4,76 HKD | -2,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
China Investment and Finance | Hong Kong | Finanziario | Servizi bancari e di Investimenti | 50% | 198,05 Mln HKD | -11,7x | -0,15 | 0,48 HKD | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Sands China | Hong Kong | Consumi ciclici | Servizi ricettivi e di intrattenimento | 46,6% | 173,60 Mrd HKD | 20,9x | 0,08 | 21,45 HKD | 4,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 23,7% Rialzo | Fai l’upgrade a Pro+ | |
OSL | Hong Kong | Tecnologia | Tecnologia finanziaria (fintech) e infrastrutture | 45,5% | 5 Mrd HKD | -21,6x | -0,6 | 8 HKD | -2,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -20,6% Ribasso | Fai l’upgrade a Pro+ | |
Remegen | Hong Kong | Salute | Ricerca medica e biotecnologica | 37,7% | 17,18 Mrd HKD | -5,5x | 0,61 | 17,58 HKD | 0,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 30,3% Rialzo | Fai l’upgrade a Pro+ | |
China Merchants China Direct | Hong Kong | Finanziario | Servizi bancari e di Investimenti | 33,6% | 2,32 Mrd HKD | 196,8x | 1,75 | 15,24 HKD | -0,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Ascentage Pharma | Hong Kong | Salute | Ricerca medica e biotecnologica | 24,6% | 12,64 Mrd HKD | -34,3x | -0,53 | 42,65 HKD | 1,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 27,8% Rialzo | Fai l’upgrade a Pro+ | |
Galaxy Entertainment Group | Hong Kong | Consumi ciclici | Servizi ricettivi e di intrattenimento | 23,6% | 161,93 Mrd HKD | 19,6x | 0,01 | 37,05 HKD | 2,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 32,2% Rialzo | Fai l’upgrade a Pro+ | |
Melco Int Development | Hong Kong | Consumi ciclici | Servizi ricettivi e di intrattenimento | 20,7% | 6,40 Mrd HKD | -6x | -0,08 | 5,07 HKD | 1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 10,8% Rialzo | Fai l’upgrade a Pro+ | |
Dynamic | Hong Kong | Immobiliare | Operazioni Immobiliari | 11,6% | 1,87 Mrd HKD | 0,3x | 0 | 7,86 HKD | 0,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
China Graphene | Hong Kong | Immobiliare | Operazioni Immobiliari | 10,1% | 451,04 Mln HKD | 25,3x | 0,48 | 0,07 HKD | -6,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Tong Tong AI Social | Hong Kong | Finanziario | Servizi bancari | 9,7% | 1,77 Mrd HKD | 16x | 0,04 | 0,32 HKD | -7,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Beigene | Hong Kong | Salute | Ricerca medica e biotecnologica | 7,7% | 12,82 Mrd HKD | -0,3x | -1,62 | 120,80 HKD | -2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 41,2% Rialzo | Fai l’upgrade a Pro+ | |
Capital Estate | Hong Kong | Finanziario | Servizi bancari e di Investimenti | 6,4% | 80,65 Mln HKD | 15,2x | 0,12 | 0,40 HKD | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Sunwah Kingsway Capital | Hong Kong | Finanziario | Servizi bancari e di Investimenti | 5,7% | 166,77 Mln HKD | -3x | -0,1 | 0,22 HKD | -3,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Orient Securities Int | Hong Kong | Finanziario | Servizi bancari | 0% | 19,49 Mln HKD | 6,9x | 0,02 | 0,19 HKD | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Zhaoke Ophthalmology | Hong Kong | Salute | Prodotti farmaceutici | -1,5% | 731,83 Mln HKD | -3,1x | -0,06 | 1,35 HKD | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
MGM China Holdings | Hong Kong | Consumi ciclici | Servizi ricettivi e di intrattenimento | -3,2% | 38,24 Mrd HKD | 8,4x | 0,03 | 10,04 HKD | 0,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Pinestone Capital | Hong Kong | Finanziario | Servizi bancari e di Investimenti | -4% | 59,02 Mln HKD | -4,8x | -0,06 | 0,22 HKD | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Yinsheng Digifavor | Hong Kong | Tecnologia | Servizi di telecomunicazione | -7,9% | 1,22 Mrd HKD | 30,6x | 0,16 | 2,94 HKD | 1,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
DT Capital | Hong Kong | Finanziario | Società di investimenti | -9,7% | 166,85 Mln HKD | -20,3x | -0,29 | 0,06 HKD | 1,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Mabpharm | Hong Kong | Salute | Ricerca medica e biotecnologica | -11,4% | 1,28 Mrd HKD | -5,9x | 0,87 | 0,31 HKD | 1,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Far East Intl | Hong Kong | Immobiliare | Operazioni Immobiliari | -13% | 44,78 Mln HKD | -0,1x | 0 | 0,04 HKD | 2,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Sirnaomics | Hong Kong | Salute | Ricerca medica e biotecnologica | -17,9% | 234,40 Mln HKD | -0,4x | -0,13 | 2,80 HKD | -1,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ |